Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
NVision Imaging Technologies
company
About
Quantum MRI agents for assessing early patient response to treatment at the metabolic level
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $2.40M
- Industries
- Biopharma,Biotechnology,Health Care,Health Diagnostics,Medical,Medical Device,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
NVision has developed a platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via MRI. This technology will allow clinicians to quickly determine which patients are responding to cancer therapies, allowing non-responders to be moved onto another line of therapy more quickly. The company was founded in 2015 and is based in Ulm, Germany.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.40M
NVision Imaging Technologies has raised a total of
$2.40M
in funding over 2 rounds. Their latest funding was raised on
Aug 1, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 1, 2021 | Grant | $2.40M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
